Is it time to include older adults in inflammatory bowel disease trials? A call for action-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is it time to include older adults in inflammatory bowel disease trials? A call for action

Published:2022-05 Issue:5 Volume:3 Page:e356-e366
ISSN:2666-7568
Container-title:The Lancet Healthy Longevity
language:en
Short-container-title:The Lancet Healthy Longevity

Author:

Vieujean Sophie,Caron Bénédicte,Jairath Vipul,Benetos Athanase,Danese Silvio,Louis Edouard,Peyrin-Biroulet Laurent

Funder

Fonds De La Recherche Scientifique - FNRS

Publisher

Elsevier BV

Subject

Family Practice,Psychiatry and Mental health,Geriatrics and Gerontology,Health (social science)

Reference205 articles.

1. Inflammatory bowel disease: a Canadian burden of illness review;Rocchi;Can J Gastroenterol,2012

2. Epidemiology and natural history of inflammatory bowel diseases;Cosnes;Gastroenterology,2011

3. Epidemiology and long-term outcome of inflammatory bowel disease diagnosed at elderly age—an increasing distinct entity?;Jeuring;Inflamm Bowel Dis,2016

4. Past and future burden of inflammatory bowel diseases based on modeling of population-based data;Coward;Gastroenterology,2019

5. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study;Charpentier;Gut,2014

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frailty: An Underappreciated Risk Factor for IBD Complications;Current Gastroenterology Reports;2024-09-05

2. A Study of Patient Concerns in the Modern Therapeutic Era of Inflammatory Bowel Disease;Inflammatory Bowel Diseases;2024-08-27

3. Cardiovascular Risk in Patients with Inflammatory Bowel Diseases—The Role of Endothelial Dysfunction;Diagnostics;2024-08-08

4. IBD Is Like a Tree: Reflections From Older Adults With Inflammatory Bowel Disease;Inflammatory Bowel Diseases;2024-06-27

5. Similar Efficacy of Mesalazine in Adult and Older Adult Ulcerative Colitis Patients: Post Hoc Analysis of a Randomized Noninferiority Trial of 1600 mg vs 400 mg Tablets;Inflammatory Bowel Diseases;2024-06-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3